Literature DB >> 15194759

Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gammaherpesvirus latency.

James Scott McClellan1, Scott A Tibbetts, Shivaprakash Gangappa, Kelly A Brett, Herbert W Virgin.   

Abstract

We have previously demonstrated that it is possible to effectively vaccinate against long-term murine gammaherpesvirus 68 (gamma HV68) latency by using a reactivation-deficient virus as a vaccine (S. A. Tibbetts, J. S. McClellan, S. Gangappa, S. H. Speck, and H. W. Virgin IV, J. Virol. 77:2522-2529, 2003). Immune antibody was capable of recapitulating aspects of this vaccination. This led us to determine whether antibody is required for vaccination against latency. Using mice lacking antigen-specific antibody responses, we demonstrate here that antibody and B cells are not required for vaccination against latency. We also show that surveillance of latent infection in normal animals depends on CD4 and CD8 T cells, suggesting that T cells might be capable of preventing the establishment of latency. In the absence of an antibody response, CD4 T cells but not CD8 T cells are required for effective vaccination against latency in peritoneal cells, while either CD4 or CD8 T cells can prevent the establishment of splenic latency. Therefore, CD4 T cells play a critical role in immune surveillance of gammaherpesvirus latency and can mediate vaccination against latency in the absence of antibody responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194759      PMCID: PMC421676          DOI: 10.1128/JVI.78.13.6836-6845.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Murine gammaherpesvirus 68 cyclin D homologue is required for efficient reactivation from latency.

Authors:  A T Hoge; S B Hendrickson; W H Burns
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Latent antigen vaccination in a model gammaherpesvirus infection.

Authors:  E J Usherwood; K A Ward; M A Blackman; J P Stewart; D L Woodland
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

3.  Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages.

Authors:  E Flaño; S M Husain; J T Sample; D L Woodland; M A Blackman
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

Review 4.  Mouse and human dendritic cell subtypes.

Authors:  Ken Shortman; Yong-Jun Liu
Journal:  Nat Rev Immunol       Date:  2002-03       Impact factor: 53.106

5.  The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency.

Authors:  L F van Dyk; H W Virgin; S H Speck
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 6.  Dissecting the host response to a gamma-herpesvirus.

Authors:  P C Doherty; J P Christensen; G T Belz; P G Stevenson; M Y Sangster
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

7.  T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice.

Authors:  L Liu; E J Usherwood; M A Blackman; D L Woodland
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

8.  Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells.

Authors:  A Khanolkar; H Yagita; M J Cannon
Journal:  Virology       Date:  2001-08-15       Impact factor: 3.616

9.  Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68.

Authors:  N P Sunil-Chandra; J Arno; J Fazakerley; A A Nash
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

10.  Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells.

Authors:  E J Usherwood; D J Roy; K Ward; S L Surman; B M Dutia; M A Blackman; J P Stewart; D L Woodland
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  15 in total

1.  An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection.

Authors:  Rebecca L Sparks-Thissen; Douglas C Braaten; Scott Kreher; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 2.  Immune regulation of viral infection and vice versa.

Authors:  Herbert W Virgin
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  CD4 T cells mediate killing during persistent gammaherpesvirus 68 infection.

Authors:  Kathleen A Stuller; Emilio Flaño
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

4.  Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression and reactivation from latency.

Authors:  Erik S Barton; Mary L Lutzke; Rosemary Rochford; Herbert W Virgin
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  An optimized CD8+ T-cell response controls productive and latent gammaherpesvirus infection.

Authors:  Douglas C Braaten; Rebecca L Sparks-Thissen; Scott Kreher; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  CD8+ T cells require perforin to clear West Nile virus from infected neurons.

Authors:  Bimmi Shrestha; Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  LXR Alpha Restricts Gammaherpesvirus Reactivation from Latently Infected Peritoneal Cells.

Authors:  P T Lange; C N Jondle; E J Darrah; K E Johnson; V L Tarakanova
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

8.  Type I Interferon Signaling to Dendritic Cells Limits Murid Herpesvirus 4 Spread from the Olfactory Epithelium.

Authors:  Clara Lawler; Philip G Stevenson
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

9.  The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus.

Authors:  Bimmi Shrestha; Terry Ng; Hsien-Jue Chu; Michelle Noll; Michael S Diamond
Journal:  Vaccine       Date:  2008-02-20       Impact factor: 3.641

10.  Antibody is critical for the clearance of murine norovirus infection.

Authors:  Karen A Chachu; David W Strong; Anna D LoBue; Christiane E Wobus; Ralph S Baric; Herbert W Virgin
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.